Pfizer's shares surged after the company announced a deal with the Trump administration to reduce U.S. drug prices, allowing Medicaid to purchase its medications at lower rates. This agreement, which aligns with the government's broader plan including the launch of the website TrumpRx, aims to provide discounted pharmaceuticals to cash-paying consumers. In response to a 60-day ultimatum from President Trump, Pfizer will cut prices on select popular drugs by up to 85%, and the broader market reacted positively with significant gains in major indices.
“Pfizer · shares were up after news that · the drug company is close to making a deal with the Trump administration · a little”
“the deal · will allow · Medicaid to buy Pfizer's drugs at lower prices · true”
“the White House · is getting ready to establish · a website called TrumpRx · true”
“TrumpRx · would let Americans who pay cash buy pharmaceuticals straight from · the government at lower prices · true”
“President Donald Trump · told drug company executives that they had · 60 days to bring U.S. prescription costs in line with his 'most-favored-nation' policy · true”
“the date · passed on · Monday · true”
“letters · went to · Pfizer CEO Albert Bourla and leaders from other drug companies · true”
“Pfizer · may benefit in the short term from · being the first to make a deal · true”
“S&P 500 Index · closed up · percentage · +0.41%”
“Dow Jones Industrials Index · closed up · percentage · +0.18%”
“Nasdaq 100 Index · closed up · percentage · +0.28%”
“Pfizer · agreed to slash · drug prices · up to 85%”
